Zeranol


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:14636701IVR5 mg/kg 5 mg/kgAffects cytokine signalingImmunological endocrine-mediated perturbations
IVR5 mg/kg 5 mg/kgDecreased uterine weightsReproductive endocrine-mediated perturbations
PMID:15646816IVR10 mg/kg 10 mg/kgIncreased ovarian weightsReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgAbnormal estrous cyclesReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgAlterations in vaginal openingReproductive endocrine-mediated perturbations
IVR0.1 mg/kg 0.1 mg/kgAlterations in vaginal openingReproductive endocrine-mediated perturbations
IVR0.1 mg/kg 0.1 mg/kgAbnormal estrous cyclesReproductive endocrine-mediated perturbations
PMID:21318220IVTH0.000001 M 0.000001 MCancer phenotypeEndocrine-mediated cancer
IVTH0.0000002 M 0.0000002 MCancer phenotypeEndocrine-mediated cancer
IVTH0.000005 M 0.000005 MCancer phenotypeEndocrine-mediated cancer
PMID:23496416IVR12 mg 12 mgDecreased prostate weightsReproductive endocrine-mediated perturbations
IVR12 mg 12 mgTesticular atrophyReproductive endocrine-mediated perturbations
IVR12 mg 12 mgAlteration in prostate morphologyReproductive endocrine-mediated perturbations
IVR12 mg 12 mgDecreased testis weightsReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.